Ignite Creation Date:
2025-12-24 @ 10:13 PM
Ignite Modification Date:
2026-02-23 @ 6:14 PM
Study NCT ID:
NCT00678535
Status:
COMPLETED
Last Update Posted:
2014-07-21
First Post:
2008-05-13
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Erbitux in Combination With Xeloda and Cisplatin in Advanced Esophago-gastric Cancer
Sponsor:
Merck KGaA, Darmstadt, Germany
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
EMR 200048-052
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None